Trials / Completed
CompletedNCT04945408
Longitudinal Description of Hemorrhoidal Pathology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Fondation Hôpital Saint-Joseph · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hemorrhoidal disease is a common cause of gastroenterology visits. In the United States, it is considered the 3rd most common gastrointestinal diagnosis with nearly 4 million scheduled or emergency visits. In France, self-reported questionnaires estimate that one person in five has suffered at least one hemorrhoidal attack in the past year.
Detailed description
Hemorrhoidal disease significantly alters the quality of life, can be life threatening in case of heavy bleeding and has a significant economic impact. However, there are still many unknowns regarding the different types of hemorrhoidal disease, its symptoms, its natural history, its etiology, its triggering and promoting factors, the associated pathologies, the therapeutic indications, etc. In addition, the therapeutic management is not consensual, especially since the therapeutic arsenal is constantly expanding over the last 20 years with the advent of minimally invasive surgical techniques. The aim of the work is to answer some of these questions on the basis of a prospective cohort of patients.
Conditions
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2021-06-15
- Completion
- 2023-03-06
- First posted
- 2021-06-30
- Last updated
- 2023-03-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04945408. Inclusion in this directory is not an endorsement.